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Aged hematopoietic stem cells (HSCs) do
not accumulate more mutations than
young HSCs upon DNA damage. Moehrle
et al. demonstrate that both young and
aged HSCs lack a G1-S arrest and a high
level of apoptosis upon DNA damage,
rendering them resilient toward acquiring
mutations upon DNA damage.
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Whether aged hematopoietic stem and progenitor
cells (HSPCs) have impaired DNA damage repair is
controversial. Using a combination of DNA mutation
indicator assays, we observe a 2- to 3-fold increase
in the number of DNAmutations in the hematopoietic
system upon aging. Young and aged hematopoietic
stem cells (HSCs) and hematopoietic progenitor cells
(HPCs) do not show an increase in mutation upon
irradiation-induced DNA damage repair, and young
and aged HSPCs respond very similarly to DNA dam-
age with respect to cell-cycle checkpoint activation
and apoptosis. Both young and aged HSPCs show
impaired activation of the DNA-damage-induced
G1-S checkpoint. Induction of chronic DNA double-
strand breaks by zinc-finger nucleases suggests
that HSPCs undergo apoptosis rather than faulty
repair. These data reveal a protective mechanism in
both the young and aged hematopoietic system
against accumulation of mutations in response to
DNA damage.
INTRODUCTION
Hematopoietic stem cells (HSCs) are tissue-specific stem cells
that reside in the bone marrow (BM) and ensure the lifelong pro-
duction of blood cells. This is achieved by the ability of HSCs to
differentiate into a variety of specialized cells and to self-renew
to achieve tissue homeostasis. HSC function declines from
adulthood to old age, which contributes hematopoiesis dysfunc-
tion in older adults. Aging of HSCs and the hematopoietic system
is characterized by senescence-associated immune remodeling2412 Cell Reports 13, 2412–2424, December 22, 2015 ª2015 The Auand anemia (Van Zant and Liang, 2012; Geiger et al., 2013). Aged
HSCs exhibit reduced self-renewal activity and a deficiency in
their ability to produce erythrocytes and show a bias toward
the myeloid lineage (Linton and Dorshkind, 2004; Signer and
Morrison, 2013). Furthermore, aged HSCs present with a distinct
gene expression signature and apolar distribution of proteins
compared to young HSCs (Chambers et al., 2007; Florian
et al., 2012).
The paradigm of the DNA damage theory of stem cell aging
states that aging-associated changes in the DNA repair system
in HSCs, together with changes in cell-cycle regulation due to
increased DNA damage with age (Pietras et al., 2011; Rossi
et al., 2007a), are thought to result in elevated DNA mutations,
which then causally contribute to the decrease in HSC function
with age. The paradigm is in part based on the finding that mice
lacking a distinct set of DNA damage repair proteins display
reduced function ofHSCs, including an impaired repopulating po-
tential and an overall depletion of the HSC pool (Ito et al., 2004;
Navarro et al., 2006;Nijnik et al., 2007;Parmaret al., 2010;Prasher
et al., 2005;Reeseetal., 2003;Rossi et al., 2007a;Ruzankinaetal.,
2007; Zhang et al., 2010; Geiger et al., 2013), although in naturally
agedmice, there is actually an expansion of the number of pheno-
typic stemcells instead of a depletion of the HSCpool. HSCaging
also correlates with an increase in DNA double-strand breaks
(DSBs). Both human and mouse HSCs present upon aging with
a2- to3-foldelevatednumberofgH2AX foci, abonafidesurrogate
marker forunresolvedDSBs (Rossi etal., 2007a;R€ubeetal., 2011).
Unresolved DSBs accumulated in quiescent, but not cycling,
HSCs upon aging (Beerman et al., 2014). gH2AX foci though
were very recently shown to co-localize in HSCs with proteins
associatedwith replicationand ribosomalbiogenesisstress (Flach
et al., 2014), rendering gH2AX foci as a general marker for persis-
tent DNA DSBs in HSCs questionable.
Signaling cascades activated in HSCs in response to DNA




Figure 1. Distinct DNA Damage Checkpoint Activation Dynamics in Young and Aged HSCs upon Irradiation
(A) Experimental setting and gating strategy. Young (2–3 months) and aged (18–24 months) C57Bl6 mice were irradiated with 3 or 7 Gy. After 16 hr, 500 mg BrdU
permousewas injected intraperitoneally, and themicewere sacrificed 45min later. BMwas isolated and lineage cells, c-Kit+ cells, LSK cells, and LT-HSCswere
analyzed by flow cytometry. Each population was scanned for cell-cycle status (BrdU incorporation over DNA content) and apoptosis (Annexin V+).
(legend continued on next page)
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The cascades might run in parallel, comprising initiation of DNA
repair (intact or erroneous repair), apoptosis as well as senes-
cence and differentiation signaling. DNA double-strand breaks
(DSBs) can also be very potent inducers of cellular senescence
in murine and human fibroblasts and murine HSCs (Di Leonardo
et al., 1994; Nakamura et al., 2008; Shao et al., 2014). Differenti-
ation in response to DNAdamage has been described for various
tissues including HSCs, melanocytic stem cells and embryonic
stem cells (Inomata et al., 2009; Li et al., 2012; Wang et al.,
2012). DNA damage induces apoptosis by p53-dependent and
p53-independent pathways, and in lymphocytes and germ
cells for example apoptosis represents the primary response to
DNA damage (Lee et al., 1998). In murine HSCs, DNA damage
induced by telomere attrition or DNA DSBs leads to an induction
of lymphoid differentiation (Wang et al., 2012). Quiescent murine
hematopoietic stem and progenitor cells (HSPCs) that aremostly
residing in G0 phase of the cell cycle are thought to undergo an
error-prone NHEJ pathway to repair DSBs (Mohrin et al., 2010).
Upon irradiation, HSCs enter the cell cycle via elevation of p21,
which implies that HSCs might use an error-free homologous
recombination (HR) pathway to repair DNA damage (Insinga
et al., 2013; Beerman et al., 2014). However, the outcome of
DNAdamage in HSCswith respect tomutational load upon dam-
age resolution as well as stem cell function in correlation to aging
has not been investigated in great detail.
In this studywe therefore investigated DNAdamage outcomes
of aged and youngHSPCs inmore detail. Aging resulted in a 2- to
3-fold increase of the mutational load in the hematopoietic sys-
tem. DNA damage response and outcomes in response to irradi-
ation or chronic individual DSBs in young and agedHSCs though
were similar. HSCs, both young and aged, were also very resil-
ient toward further accumulation of DNA mutations in response
to damage, which might be linked to unexpected differences in
the DNA damage response between HSCs and differentiated
cells regarding G1/S cell-cycle checkpoint activation. Collec-
tively, we show that differentiated cells and HSCs respond differ-
ently to DNA damage, while the response is very similar for
young and aged HSCs with respect to mutation accumulation
and fitness in response to DNA DSBs.
RESULTS
Distinct DNA Damage Checkpoint Activation in HSCs
upon Irradiation
DNA damage induces cell-cycle checkpoints as well as
apoptosis, which are critical signaling cascades that directly
impact DNA damage outcomes (Kastan and Bartek, 2004). Mu-
rine embryonic fibroblasts (MEFs), cell lines, and differentiated
primary cells activate a G1/S cell-cycle checkpoint upon DNA
damage through inhibition of the transcription factor E2F by(B) Total number of Lin+, Lin, c-Kit+, LSK, and LT-HSC cells per tibiae and fem
*p < 0.05, **p < 0.005, ***p < 0.001, ****p < 0.0001; columns represent means +1
(C and D) Percentage of cells in either G0/G1 or S phase of the cell cycle. *p < 0
columns represent means +1 SEM; young control n = 5, young 7 Gy n = 3, old c
(E and F) Percentage of Annexin V+ cells either in G0/G1 or S phase of the cell cyc
(columns represent means +1 SEM); young control n = 5, young 7 Gy n = 3, old
See also Figure S1.
2414 Cell Reports 13, 2412–2424, December 22, 2015 ª2015 The Authe retinoblastoma (Rb) repressor complex. This results in a tran-
scriptional arrest and a halt of progression into S phase and is re-
garded as a hallmark of theDNAdamage response. Interestingly,
embryonic stemcells skip activationof theG1/Scheckpoint upon
DNA damage (Aladjem et al., 1998; Hirao et al., 2000; Hong and
Stambrook, 2004). We thus first asked which DNA-damage
checkpoints are active in HSCs and whether at stage of check-
point activation HSCs undergo apoptosis in response to DNA
damage. To this end, flow cytometry assays to measure cell-cy-
cle profiles and at the same time apoptotic status of young and
aged HSPCs and differentiated hematopoietic cells were per-
formed 16 hr after in vivo irradiation (Figure 1A). In response to
7 Gy (sublethal) irradiation, the total number of young and aged
hematopoietic progenitor cells (c-Kit+ cells), early hematopoietic
progenitor cells (LSK cells), and long-term repopulating HSCs
(LT-HSCs), but not yet that of terminally differentiated (Lin+) cells
(Figure 1B), was significantly reduced. These data are consistent
with a positive correlation between radiation sensitivity and prim-
itiveness of hematopoietic cells.
Differentiated hematopoietic cells (Lin+ as well as Lin cells)
presented with the same frequency of cells in G0/G1 upon irradi-
ation, while more primitive young as well as aged c-Kit+, LSK, or
LT-HSCs showed a lower frequency of cells in G0/G1. This im-
plies an impaired activation of the G1-S checkpoint in primitive
hematopoietic cells (PHCs) (Figures 1C and 1D). All cell types
accumulated to a similar extent in the G2/M phase upon irradia-
tion, implying a functional G2/M or mitotic checkpoint (Fig-
ure S1A). The impaired activation of the G1-S checkpoint was
not restricted to the C57BL/6 strain (HSCs from DBA/2 mice
show a similar phenotype) and can already be observed at lower
doses of irradiation (Figures S1C, S1D, and S2C). An impaired
activation of the G1-S restriction checkpoint upon DNA damage
was further implied by the finding that the frequency of HSPCs
(c-Kit+, LSK, and LT-HSCs) in S phase of the cell cycle increases
upon irradiation (Figure 1D).
Loss of the retinoblastoma (Rb) protein in fibroblasts results in
a loss of a G1-S checkpoint activation and genetic instability (van
Harn et al., 2010). A lack of G1-S activation in HSPCs would thus
render Rb in HSCs dispensable with respect to the DNA damage
response. We therefore tested activation of DNA damage
signaling in hematopoietic cells deficient for Rb (Rb HemKO; Da-
ria et al., 2008). Consistent with our prediction, HSPCs devoid of
Rb did not show any difference in checkpoint activation upon
irradiation nor in the number of gH2AX foci or tail length in a
comet assay, another surrogate assay for DNA strand breaks
(Figures S2A–S2C). However, we observed a small but signifi-
cant increase of cells in S-phase of the cell cycle in steady state
in RbHemKOmice (Figure S2C), supporting a role for Rb in regu-
lation of the G1/S checkpoint in HSPCs with respect to basic
proliferation.ur determined by flow cytometry 16 hr after total body irradiation with 7 Gy.
SEM; n = 5.
.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 statistics relative to control group;
ontrol n = 5, old 7 Gy n = 5.
le. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 statistics relative to control
control n = 5, old 7 Gy n = 5.
thors
Activation of the G1-S checkpoint is supposed to stop a cell
from entering S phase of the cell division cycle to allow for DNA
repair processes in G0/G1, which in turn inhibit apoptosis initi-
ated by the DNA damaging event (Sancar et al., 2004). Our ana-
lyses revealed that differentiated hematopoietic cells showed
low levels of apoptosis in G0/G1 phase in response to irradiation
and elevated levels in the S and G2-M stages of the cell division
cycle (Figures 1E, 1F, and S1B). Surprisingly, there was already
a strong induction of apoptosis in G0/G1 in more primitive cells
(c-Kit+, LSK, and LT-HSCs) in response to irradiation, with levels
of apoptosis remaining high in S and G2-M. This indicated that
HSPCs undergo apoptosis in response to irradiation, indepen-
dent of their cell-cycle checkpoint position.
The lack of G1-S checkpoint activation correlated with very
low levels of expression of the checkpoint kinase Chk2 (critical
for G0/G1 checkpoint activation) in HSPCs upon irradiation
(data not shown) as well as sequestration of Chk2 to the Pericen-
trin-2-positive centrosome in primitive hematopoietic cells, most
likely rendering Chk2 ineffective (Figure S2D). Elevated expres-
sion of Chk2 in hematopoietic cells activated a G0/G1 arrest
upon DNA damage while maintaining the relatively high level of
apoptosis already seen in G0/G1. This resulted in impaired
stem and progenitor cell function in transplantation assays (Fig-
ures S2E–S2G), which was dependent on the kinase function of
Chk2. These data imply that induction of Chk2 expression acti-
vates a G0/G1 checkpoint in HSPCs at the expense of a high
level of apoptosis upon DNA damage (see Figures 1E and 1F).
In summary, young as well as aged HSPCs actively suppress
activation of the G1-S checkpoint upon irradiation and present
at the same time with high levels of apoptosis upon DNA dam-
age, independent of their position within the cell division cycle.
Robust Protection of Genomic Integrity in Young and
Aged HSCs
Various reports indicate persistence of DNA damage after irradi-
ation in HSCs and elevated steady-state damage in aged HSCs
(Rossi et al., 2007b; Mohrin et al., 2010; Insinga et al., 2013)
or elevated levels of stalled replication forks (Flach et al.,
2014). We therefore determined the frequency of gH2AX foci in
response to irradiation in young and aged LT-HSCs, which
has been regarded as a surrogate marker for the frequency of
DSBs in the genome. Aged LT-HSCs presented with a small,
but significant increase in the number of foci per cell as also pre-
viously reported (Beerman et al., 2014; Flach et al., 2014; Rossi
et al., 2007a) (Figure S3A). The comet assay quantifies changes
in DNA migration caused by DSBs, alkaline labile sites, and
transient repair sites. Aged LT-HSCs presented with a minor
elevated tail moment under steady-state conditions compared
to young cells (Figure S3B) (see also Beerman et al., 2014).
Both young and aged LT-HSCs presented with a similar abso-
lute increase in the tail moment as well as gH2AX foci number
after irradiation. Interestingly, theses changes were not linked
to oxidative stress, since levels of 8-oxo-dG (a quantitative
marker of oxidative damage of DNA) did not show significant
differences between young and aged LT-HSCs in steady state
and after irradiation (Figure S3C).
We also determined the loss of heterozygosity (LOH) at
distinct microsatellite marker locations to further quantify theCell Repoutcome of DNA damage. Monoclonal colonies (from a CFC
assay) derived from individual young and aged hematopoietic
progenitor (LK cells) as well as early hematopoietic progenitor
cells (LSK cells) presented with similar LOH frequency. Upon
irradiation at 5 Gy ex vivo, aged LSK presented with a 2- to
3-fold increase in the LOH frequency compared to young LSK
cells (Table S1). The CFC assay is performed under supraphysio-
logical cytokine conditions, which have been reported to sup-
press apoptosis in hematopoietic cells upon irradiation (Chute
et al., 2004; He´rodin and Drouet, 2005). The extent in increase
in LOH frequency is similar in magnitude to the increase, for
example, in tail moment of aged HSCs in the comet assay
(Figure S3B).
To test whether DNA damage will alter stem cell function
in vivo distinctly in young and aged HSPCs, competitive trans-
plantation/irradiation/recovery experiments were performed in
which young and aged HSCs directly functionally compete
post-DNA-damage in the same recipient animal. Functionality
of young and aged HSCs is indicated by the level of chimerism
of donor cells in peripheral blood 3 months post-irradiation.
We detected almost identical chimerism ratios of old (Ly5.2+)
versus young cells (remaining cells, Ly5.1+) in control versus
irradiated animals (Figures 2A and 2B), strongly implying
that stem cell function upon irradiation is very similar in young
and aged HSCs. This conclusion is further supported by
our finding that young and aged stem and progenitor cells
showed almost identical survival frequencies upon irradiation
in various functional in vitro assays (cobblestone-area-forming
cell [CAFC] assay as well as colony-forming cell assays; data
not shown).
Using a validated and widely accepted transgenic plasmid
based mutation detection assay (Figure 2C) (Boerrigter et al.,
1995; Geiger et al., 2006, 2009), we next analyzed DNA repair
outcomes in hematopoiesis with respect to fidelity of the DNA
damage repair process in vivo by determining mutation fre-
quencies in response to DNA damage. Mutation frequencies in
BM cells from transgenic mice were determined in response to
total body irradiation (3 Gy) 4 days (resembling activity of differ-
entiated cells), 28 days (indicative of progenitor cell activity), and
3 months (hematopoiesis indicative of HSCs activity) after irradi-
ation. BM cells in aged mice had a trend toward an increased
mutational load in steady-state hematopoiesis (2-fold) (Fig-
ure 2D). The majority of mutations detected were translocations
and/or deletions (data not shown) and not point mutations, which
is a unique pattern ofmutations among all tissues analyzed so far
with this indicator strain (Dolle´ et al., 2000). Surprisingly, the
mutation frequency in BM cells did not increase in response to
irradiation. To the contrary, the mutation frequency significantly
decreased 28 days postirradiation in BM cells as well as at
3months post-irradiation in both age groups, with translocations
still being the majority of the remaining mutations (Figure 2D and
S3D). This implies that the DNA damage response of the he-
matopoietic system avoids accumulation of genomic mutations
upon irradiation and this mechanism remains fully intact in aged
animals. The data also demonstrate that young and aged HSPCs
show a similar in vivo response to DNA damage and a similar
DNA damage repair outcome in response to irradiation, with an




Figure 2. Protection of Genomic Integrity in Young and Aged Hematopoietic Cells upon DNA Damage In Vivo
(A) Schema of experimental setup.
(B) Chimerism of Ly5.2+ cells within the different hematopoietic compartments. Control n = 5, 3 Gy n = 7; PB, peripheral blood; BM, bone marrow; SPL, spleen,
THY, thymus, LSK, lineage-negative/c-Kit+/Sca-1+ BM cells; HSPC, hematopoietic stem and progenitor cells. Columns represent means +1 SEM. See also
Figure S2.
(C) Experimental setup of the assays to determine genomic mutations (see Experimental Procedures for details).
(D) Mutation frequency (number of mutated plasmids per 104 plasmids analyzed) of BM cells derived from young (2–3 months) and aged (18–24 months) mice
before and 4 days, 28 days, and 3 months after irradiation with 3 Gy. n = 18 for young, n = 5 for aged, n = 7 for young (90 days), n = 5 for aged 90 days, n = 3 for
young (4 days, 28 days) and aged 28 days, and n = 2 for aged 4 days; *p < 0.05, **p < 0.01, ****p < 0.0001 (compared to values after 4 days within group), xp < 0.05,
xxp < 0.05 (compared to values before irradiation within group), #p = 0.0524 (Y compared to O); columns represent means +1 SEM.





Figure 3. Confirmation of In Vivo Activity of a
lacZ-Specific Zinc-Finger Nuclease
(A) Each three-finger zinc finger (F1, F2, and F3)
linked to the FokI nuclease domain (zinc-finger
nuclease [ZFN] binds to a 9-bp half of a palindromic
pUR288 plasmid target site. The amino acid se-
quences of the zinc-finger domains (F1, F2, F3) of
the two ZFNs (1.25 and 1.34) are depicted.
(B) Schematic representation of the SSA assay. In
the assay, the activity of the ZFN is proportional to
the expression of GFP.
(C) Activity of the ZFNs relative to a positive stan-
dard. n = 3. Columns represent means +1 SEM.
(D) ZFN toxicity assay: survival of fibroblasts co-
transfected with a GFP plasmid and either with the
ZFN or with the non-toxic endonuclease I-Sce-I
(negative control) or caspase-activated DNase
(CAD, positive control), n = 3. Columns represent
means +1 SEM.
(E) Gammaretroviral bicistronic SF91/ZFN-IRES-
eGFP vector used for stable transduction of cells
(LTR, long terminal repeat with strong enhancer
element; wPRE, woodchuck hepatitis virus post-
transcriptional regulatory element).
(F) Expression of the ZFNs 1.25 and 1.34 and actin
in fibroblasts transduced with the SF91/ZFN-IRES-
eGFP vector (representative western blot).
(G) Schematic representation of experimental
setup. Agarose gel electrophoreses of pUR288
plasmid incubated with nuclear extracts for 1 or 3 hr
from cells transduced with the SF91/ZFN-IRES-
eGFP virus containing the ZFNs, pUR288 alone
(negative control) and pUR288 digested with the
restriction enzyme HindIII (positive control).
(H) Schematic representation of experimental setup.
Representative southern blot against pUR288. CTL,
genomic DNA digested with HindIII (positive control).
The linear plasmid has a size of 5.3 kb.In summary, both young and aged PHCs strongly avoid having
DNA-damaged cells in the G0/G1 state. They present with a high
level of apoptosis upon DNA damage induced by irradiation and
show for a selective type of DNA mutations (LOH) in response to
in vitro damagea2- to3-fold increase,whileDNA-damage-surviv-
ing cells in vivo do not accumulate DNAmutations as determined
by the indicator strain. These data imply a mechanism of either
repairwithanoverall lowerror rateor a strongselection for undam-
agedcells.Also, clearingofdamagedcells thatexceeda threshold
for a still-tolerated mutation number or induction of replicative
senescence might contribute to this outcome. This suggests
that the hematopoietic system is activelymanaging theDNAdam-
age response outcome in vivo with respect to mutational load.
Generation of a Defined DNA DSB In Vivo in Stem Cells
via a lacZ-Specific Zinc-Finger Nuclease
We further tested this ‘‘reduce the mutational load upon
damage’’ hypothesis of PHCs in vivo. Specifically, a definedCell Reports 13, 2412–2424, DDSB was induced by homodimeric zinc-
finger nucleases (ZFNs) (we generated
two distinct ZFNs versions, 1.25 and
1.34; Figure S4A) specific to a palindromictarget site within the lacZ gene (at bp 407–430; Figure 3A)
(Maeder et al., 2009). ZFNs bind as dimers to their specific target
site (in our case lacZ, transgenic mouse) and a DNA DSB is
generated via the attached Fok1 nuclease within the spacer
region (6 bp), separating the two binding domains (9 bp each;
Figure 3A). A plasmid-based single-strand annealing repair
assay in which the activity of the ZFN is proportional to the
expression of GFP (Porteus and Baltimore, 2003) demonstrated
increased activity of the zinc fingers relative to standard controls
(113% for 1.25 and 192% for 1.34; Figures 3B and 3C). A cell sur-
vival assay, in which the nontoxic endonuclease I-SceI from
yeast was used as a negative standard for reference and trans-
fection with caspase-activated DNase (CAD) served as positive
control, revealed no toxicity of the zinc fingers and thus no un-
specific off-target activity (Figure 3D). Transfection with ZFNs
did not result in a significantly elevated number of gH2AX foci
in cells containing no lacZ target site (data not shown), further
confirming specificity of the ZFNs for their target site. For stableecember 22, 2015 ª2015 The Authors 2417
expression of the ZFNs in cell lines and HSCs, a bicistronic retro-
viral vector SF91/ZFN-IRES-eGFPwas used (Figure 3E). Expres-
sion of ZFN proteins was confirmed by western blotting of cells
transduced with the ZFNs (Figure 3F). To further determine activ-
ity in vivo, we next investigated the activity of nuclear extracts
from eGFP+ fibroblast cells transduced with the ZFNs on purified
pUR288 plasmid containing the lacZ target sequence. Incubation
of the plasmid for 1 hr with the nuclear extract resulted in lineari-
zation of the plasmid (5.3-kb band), which intensified in response
to a 3-hr incubation, confirming specific ZFN activity in nuclear
extracts (Figure 3G). In order to verify activity on genomic lacZ
DNA in vivo, DNA from lacZ murine (small blue mouse) cells,
which were transfected with the ZFN 8 hr prior to analysis by
Southern blot, was used. Since the pUR288 plasmid is integrated
as a concatemer of 20 copieswithin the genome, the creation of a
DNADSBat theZFN target site in vivowill result inDNA fragments
the size of the plasmid (5.3 kb) (Figure 3H). ZFN 1.25 displays a
distinct band at 5.3 kb, which is a unique result as usually
‘‘free’’ degradation products of ZFNs in vivo are very difficult to
track due to their short half-life in vivo. In summary, the two
ZFNs generated are active on lacZ-DNA in vivo and specific
and thus are a unique tool to determine the responseof stemcells
to defined DSBs.
Young and Aged HSCs Sense Single DSBs to Protect
Their Genome
ZFN transduced and subsequently sorted (eGFP+) Lin BM cells
from the lacZ transgenic mouse were expanded in vitro for
3 days prior to analysis to obtain the cell numbers and thus the
amount of DNA necessary for the mutation assay (Figure S4B).
Lin BM cells transduced with the lacZ-specific ZFNs showed
a slight non-significant increase in the mutation frequency (Fig-
ure S4B). This finding implies a resilience of these cells to acquire
DNA mutations, and it correlates with the fact that PHCs do not
activate a G1/S checkpoint and might thus avoid repair in G0/G1
and the DNA repair program associated with G0/G1. Mutation
frequencies in PHCs are very difficult to determine due to the
amount of DNA necessary for the assay. We instead focused
on functional assays for lacZ-positive HSCs transduced with
ZFNs. Transduced Lin cells (eGFP+) from young and aged
mice were transplanted into lethally irradiated recipient mice
(Figure 4A). 18–21 weeks after transplantation, when hematopoi-
esis in the periphery is driven by transplanted HSCs, ZFN-posi-
tive young as well as aged HSCs presented with as significant
decrease in eGFP+ cells among donor cells in PB and BM (Fig-
ures 4B and 4C). The fitness/status though of the transplanted
HSPCs was not altered right after transduction, as there was
no difference in the frequency of colony-forming activity be-
tween control and ZFN-transduced cells (Figure S4C). Because
the active ZFN will constantly target the lacZ locus in stably
transduced cells, a likely outcome is that almost all ‘‘surviving’’
eGFP+ clones show mutations in lacZ. Surprisingly, but consis-
tent with the data presented so far, the remaining small number
of eGFP+ transduced cells that could be recovered from the BM
after transplantation did present with only a very low number
of DNA mutations within the transgene (one single clone with a
point mutation at the ZFN target site in one mouse transplanted
with aged Lin cells; Figure 4D).2418 Cell Reports 13, 2412–2424, December 22, 2015 ª2015 The AuOur data therefore demonstrate that HSCs are resilient against
acquiringmutations upon DNA damage in vivo, implying a ridged
quality control mechanism to preserve genomic integrity of the
stem cell pool. Interestingly, this approach and its underlying
mechanisms are not altered upon aging of the hematopoietic
system.
DISCUSSION
The loss of maintenance of genomic integrity is central to most
theories on somatic and stem cell aging. Analysis of HSCs with
respect to the frequency of DNA damage (comet assay,
gH2AX foci, DNA mutation frequency, LOH assay) revealed an
2- to 3-fold increase in these parameters upon aging. The dif-
ference in mutation frequency in steady state between young
and aged BM cells was2-fold, which is in the range of changes
in mutation frequencies recently reported for aged human BM
cells via deep-sequencing approaches (Cancer Genome Atlas
Research Network, 2013; Genovese et al., 2014; Welch et al.,
2012). In a diploid genome that harbors 6 3 109 nt, the total
estimated mutational load per diploid BM cell is then 300
mutations in young and 600 mutations in an aged animals.
Whether such an increase upon aging is causatively linked to ag-
ing-associated diseases though still needs to be determined. A
22-fold increase in the mutational load (Geiger et al., 2006) is
able to initiate leukemia in a mutator gene type setting (Kushner
et al., 2008; Noronha et al., 2006; Su et al., 2005), while a 2- to
3-fold mutation load increase in BM cells does not induce leuke-
mia (Krejci et al., 2008). The concept of a robust response of
aged stem cells to DNA damage is further supported by the
finding that muscle stem cells do not present with a significant
accumulation of DNA damage upon aging (Cousin et al., 2013).
Might the elevated gH2AX foci and increased tail moment in
comet assays upon aging also be linked to aging-associated
changes in stem cells other than just DNA damage? In murine
hair follicle stem cells, 53BP1 foci, a mechanistic marker for
DNA DSBs, did not overlap with gH2AX foci, and instead
gH2AX foci were identified as a sign for chromatin alterations
upon aging (Schuler and R€ube, 2013). Very recently, it was
shown that elevated levels of gH2AX foci in aged HSCs can be
also associated with replication and ribosomal biogenesis stress
and might therefore not be an optimal marker for persistent DNA
damage (Flach et al., 2014). Instead, elevated levels of gH2AX
foci in aged HSCs might be linked to broader chromatin
changes, which can, but need not to be, linked to DNA damage
(Florian et al., 2012; Liu et al., 2013) Such changes might be
linked to migration velocity of DNA in assays like the comet
assay. Furthermore, it was shown by Beerman et al. (Beerman
et al., 2014) that quiescent HSCs acquire DNA damage upon
aging, but when these cells are pushed into the cell cycle, the
damage is repaired. Our data suggest a mechanistic explanation
for this finding, demonstrating that aged cells with DNA damage
are pushed into the cell cycle and either repair properly without
mutations or simply die.
In summary, we demonstrate that both young and aged HSCs
that survive irradiation are repaired properly with a low mutation
rate regardless of their age. Our data strongly imply that both the




Figure 4. Young and Aged HSCs Sense Single DSBs and Protect Their Genome
(A) Experimental setup.
(B and C) Contribution of transduced cells (GFP+/Ly5.2+ cells) to peripheral blood (PB) and bone marrow (BM) 18–21 weeks after transplantation. *p < 0.05, **p <
0.01, ****p < 0.0001; columns represent means +1 SEM, n = 3 with a cohort of three to five recipient mice per group.
(D) Number of mutations in the lacZ ZFN target site sequence in GFP+ BM cells (clone) 18–21 weeks post-transplant.acquiring mutations upon DNA damage induced by irradiation,
trying to maintain a pristine pool of HSCs contributing to hema-
topoiesis and to strongly suppressing leukemia. How is this resil-
ience achieved? Multiple cellular and molecular mechanisms
seem to contribute to that. First, LT-HSCs are more sensitiveCell Repto irradiation than their progeny as 3 Gy resulted in the loss of
LT-HSCs whereas Lin-, c-Kit+, and LSK cells did not show a sig-
nificant decrease in cell number (our own data; Mohrin et al.,
2010). Second, and probably more importantly, our results
show an unexpected loss of activation of the G1-S cell-cycleorts 13, 2412–2424, December 22, 2015 ª2015 The Authors 2419
checkpoint in HSPCs already at lower doses of irradiation
(3 Gy), which was even more pronounced after high-dose irra-
diation. Such an observation is similar to what has been
described for embryonic stem cells, which also show absence
of a G1-S checkpoint upon damage (Aladjem et al., 1998; Hong
and Stambrook, 2004). A lack of checkpoint activation in
HSPCs was further supported by our finding that deletion of
Rb in hematopoietic cells did not alter DNA damage response
parameters. One alternative hypothesis, based on these obser-
vations, is that the genetic translocations and deletions found in
leukemia cells are actually not a consequence of faulty repair
by non-homologous end-joining (NHEJ) in G0/G1 and rather
imply that translocations and deletions are generated via faulty
repair mechanisms at later stages of the cell division cycle, like
in S, G2, or M phase.
In fibroblasts, irradiation leads to a prolonged cell-cycle ar-
rest in G1 phase to halt the cell for repairing DNA damage
before entering the cell cycle (Deckbar et al., 2011; Di Leonardo
et al., 1994), whereas the same challenge could also lead
to apoptosis, senescence, or differentiation. In hematopoietic
cells, we observed that differentiated cells that do arrest in
G0/G1 phase did not undergo apoptosis, whereas more primi-
tive cells did not arrest and showed high levels of apoptosis.
Also, human CD34+ HSPCs show increased apoptosis in
response to DNA damaging agents when compared to differen-
tiated cells (Buschfort-Papewalis et al., 2002). An elevated level
of apoptosis in S phase is supported by the finding that HSPCs,
when proliferating, present with a decreased expression of
prosurvival genes compared to quiescent cells (Mohrin et al.,
2010).
Murine embryonic stem cells also lack G1-S checkpoint
activation, which is due to intracellular mislocalization of the
checkpoint kinase Chk2 (Hong and Stambrook, 2004). In mu-
rine LT-HSCs, the Chk2 protein is not expressed throughout
the nucleus, like in differentiated cells, but sequestered at
the centrosome. Ectopic expression of Chk2 in HSCs reduced
function of HSCs, which is consistent with our finding that
primitive hematopoietic cells, when in G0/G1, respond primar-
ily with apoptosis to DNA damage. Taken together, the most
likely outcome of DNA damage in a primitive hematopoietic
cell might be dual in nature: apoptosis or repair without muta-
tions. Such a model might not only hold true for DNA damage
found at multiple locations within the cell as in response to
irradiation. Our results further demonstrate that PHCs trans-
duced with a ZFN that will create one site of DSBs per cell
do not show an increase in mutation frequency. When trans-
planted, we further demonstrate that these cells are unable
to contribute to PB chimerism as they most likely undergo
apoptosis or senescence.
In aggregation, our results demonstrate a 2- to 3-fold
increase in the steady-state mutational load in the hematopoi-
etic system but almost equal DNA damage repair outcomes
in young and aged HSCs. The role for DNA damage out-
comes with respect to aging of HSPCs will need to be further
investigated. Most importantly, these data reveal a heretofore
unrecognized resilience of the hematopoietic system in gen-
eral to acquire DNA mutations in response to DNA damage
in vivo.2420 Cell Reports 13, 2412–2424, December 22, 2015 ª2015 The AuEXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice (8–12 weeks old and 18–26 months old) as well as C57BL/
6.SJL-Ptprca/Boy (BoyJ) mice were obtained from Janvier or the divisional
stock (derived from The Jackson Laboratory). L30 lacZ+ mice (Tg(LacZpl)
60Vij/J, small blue mouse, backcrossed on C57BL/6 background) were
described previously (Boerrigter et al., 1995). Mice were housed under spe-
cific-pathogen-free conditions at the University of Ulm or at the Cincinnati Chil-
dren’s Hospital Medical Center (CCHMC). Experiments were performed in
compliance with the German Law for Welfare of Laboratory Animals and
were approved by the Regierungspra¨sidium T€ubingen or the Institutional Ani-
mal Care and Use Committee at CCHMC.
Generation of a L30 lacZ+ Adult Fibroblasts Cell Line
Fibroblasts of L30 lacZ+ and lacZ mice were generated as described
before (Bosco and Knudsen, 2005). L30 lacZ+ adult fibroblasts started to
become immortalized between passages 11 and 15 and were then used for
experiments.
Mutation Assay
The mutation frequency analysis using the L30/small blue mouse model was
performed as previously described (Boerrigter et al., 1995; Dolle´ et al., 1997;
Geiger et al., 2009; Vijg et al., 1997)
Determination of Loss of Heterozygosity upon DNA Damage via
Analysis of Loss of Inbred Strain-Specific Microsatellites in B6D2F1
Mice
Clonal colonies (CFCs in completemethylcellulosemedium, STEMCELL Tech-
nologies) from Lin, c-Kit+ cells or Lin, c-Kit+ Sac-1+ cells from young
(2–3 months) or aged (22 months old) B6D2F1 mice were picked between
days 7 and 9, washed in PBS, and subsequently lysed (0.91 mg/ml Proteinase
K, 0.5% Tween20, and 0.5% Nonidet P40). DNA was subjected to multiplex
cocktails of fluorescently labeled primers that flank small tandem nucleotide
repeats (microsatellites) polymorphic in length between DBA2 and B6. PCR
amplified DNA (95C 15 min; then 38 cycles of 94C 30 s, 57C 1:30 min
and 72C 1min; 60C 30 min, and 4C forever) was analyzed by capillary elec-
trophoreses, and peak calling relative to B6 and DBA/2 controls was
performed with Gene Mapper software. (primers for LOH assay were picked
randomly among the microsatellite markers that are distinct in length between
C57BL/6 andDBA/2 and readable inmultiplex setupwhile coveringmost chro-
mosomes: D1Mit380, D9Mit123, DXMit64, D8Mit45, D12Mit143, D4Mit17,
D16Mit60, D14Mit39, D3Mit57, D18Mit177, D10Mit230, D5Mit309, D2Mit66,
D13Mit256, D19Mit96, D1Mit102, D6Mit284, D7Mit350, and D15Mit67).
Generation of lacZ-Specific Zinc-Finger Nuclease
The lacZ-specific ZFNs 1.25 and 1.34 were generated using the OPENmethod
(oligomerized pool engineering) (Maeder et al., 2009). The homodimeric
ZFN target site within the lacZ (bp 407–430, 50-TCCGGCACCAGAAGCGG
TGCCGGA-30) was identified using the web-based software provided by the
ZFN consortium. Bacterial two-hybrid (B2H) selection strains were then con-
structed harboring the ZFN target half-sites upstream of a B2H promoter.
The zinc-finger array libraries were constructed by using DNA sequences en-
coding fingers from preselected ‘‘pools’’ for each targeted triplicate (F1: GGA,
F2: GCC, F3: GGT) that were fused together by overlap PCR (Porteus, 2008).
This resulted in a library of DNA sequences encoding random combinations of
fingers. These DNA sequences were then cloned into low-copy expression
phagemids and converted into infectious phage particles that were used to
infect B2H selection cells (kanamycin/tetracycline/sucrose selection). Phage-
mids encoding the zinc-finger arrays that bind to the target site were isolated
from colonies on the selection plates, the zinc-finger array DNA sequence
amplified by PCR reaction, fused to a five-amino-acid linker sequence, and
ligated to the wild-type FokI nuclease domain. For sequences of lacZ-specific
ZFNs, see Figure S4.
For expression of the ZFN in hematopoietic cells, the bicistronic retro-
viral vector SF91/IRES-eGFP was used. Cell-free supernatants containing
retroviral particles were generated by transient transfection of Phoenix-gpthors
packaging cells (ATCC number CRL-3215) using Calcium Phosphate Trans-
fection kit (Invitrogen).
Activity of ZFNs on Target Site: SSA Assay
The full ZFN target site was inserted into repeated sequences within the GFP
gene. The reporter constructs also included the GFP1/2 full ZFN target site
(50-ACCATCTTC-ttcaag-GACGACGGC-30) as a positive control and internal
standard previously described by Pruett-Miller et al. (2008) as GFP1.4-B2H
andGFP2-B2H. These SSA reporter plasmids were used to investigate the ac-
tivity of the ZFNs on their target site. 100 ng of each ZFN-expression plasmid
and 20 ng reporter plasmid were co-transfected into HEK293 or 293T cells us-
ing the calcium phosphate transfection kit (Invitrogen). Percentage of GFP+
cells (DSB of ZFN at target site and subsequent SSA repair, restoring GFP
expression) was determined at day 2 via flow cytometry. The activities of the
ZFNs 1.25 and 1.34 were normalized to the activity of the internal standard.
Preparation of Nuclear Extract Harboring ZFNs
Nuclear extract was prepared from stably transfected L30 lacZ fibroblasts
with the SF91/ZFN-IRES-eGFP virus based on Dignam et al. (1983). Protein
concentrations obtained were between 2 and 6 mg/ml.
Activity of ZFNs on pUR288 Plasmid: Plasmid Assay
2 mg supercoiled pUR288 plasmid were incubated at 37C for 1 to 3 hr in 13
NEB buffer 2 with 50 mg nuclear extracts from cells transduced with the
SF91/ZFN-IRES-eGFP virus and applied to a 1% agarose gel. Plasmid di-
gested with HindIII served as positive control, and undigested plasmid served
as negative control.
Activity of ZFNs on Genomic DNA: Southern Blot
L30 lacZ+ fibroblasts were transfected with the ZFN plasmids using the Attrac-
tene Transfection Reagent (QIAGEN). After 8 or 18 hr, genomic DNA was iso-
lated using the total DNA purification Kit (Epicenter). As positive control, 10 mg
of L30 lacZ+ genomic DNA was digested with HindIII for 2 hr at 37C. 15 mg
genomic DNA was loaded on a 1% agarose gel. The gel was incubated with
0.2 N HCl, denatured, neutralized, and transferred overnight on a Hybond
nylon membrane (GE Healthcare) using 103 SSC buffer (pH 7). Membrane
was auto-crosslinked with 2,400 mJ UV irradiation, pre-hybridized for 1 hr at
45C with salmon sperm DNA and Roti-Hybriquick solution (Roth), and finally
hybridized with the radioactive label (32P-dCTP probe against bp 849–2,442)
overnight at 48C. After stringent washing, the membrane was exposed to a
PhosphoImager screen and analyzed using AIDA Image Analyzer and ImageJ
software. Radioactive-labeled probe was generated using the random primed
DNA labeling Kit (NEB) according to the manufacturer’s instructions.
Toxicity Assay
Toxicity assays were performed as previously described (Pruett-Miller et al.,
2008). To calculate the percent survival relative to I-SceI, the ratio after
nuclease transfection was normalized to the ratio after I-SceI transfection
and this determined the percent survival compared to I-SceI.
Western Blot Analysis of ZFN and Chk2-Protein
Transduced cells were re-suspended in Mg2+ lysis/wash buffer (Upstate Cell
Signaling Solutions) containing 10% glycerol, 25 mM sodium fluoride, 1 mM
sodium orthovanadate, and a protease inhibitor cocktail (Roche Diagnostics),
incubated for 15 min on ice, and centrifuged. Equal amounts of protein were
used for western blot analysis. ZFN was visualized using anti-FLAG-tag
antibody (OctA-Probe [D8]: sc-807, Santa Cruz). Chk2 and Chk2 KD were
detected using anti-Chk2 antibody (sc-17747 [a-11], Santa Cruz), and anti-
b-actin (Sigma) was used to determine total protein levels.
Isolation of BM and Retroviral Transduction
Lineage-negative cells from BM were pre-stimulated for 2 days in Iscove’s
modified Dulbecco’s medium (IMDM; Lonza) supplemented with 10%
fetal bovine serum (FBS), 1% penicillin/streptomycin, 2 mM L-glutamine,
50 ng/ml rat stem cell factor, 10 ng/ml mIL-3, 100 ng/mL mFlt3-ligand, and
100 ng/ml mIL-11 (Prospec) at a density of 6–83 106 cells/well. Viral transduc-
tion was performed on day 3 in RetroNectin-coated (TaKaRa) non-tissueCell Repculture plates that were preloaded with viral supernatant by centrifugation.
Pre-stimulated BM cells were seeded on top (9–9.5 3 105 cells/well), and
another layer of virus with cytokines was added. Media was changed
the next morning, and another round of transduction was carried out over-
night. The next day, cells were harvested using cell dissociation buffer (Gibco)
and GFP+ cells were sorted by FACS on a BD FACS Aria II or III (BD
Bioscience).
CFC Assay
CFC assays were performed as described elsewhere (Geiger et al., 2001; Xing
et al., 2006).
Transplantation
For competitive transplantation, equal numbers (1–2 3 106) of young
(2–4 months) Ly5.1+ total BM cells and aged (18–24 months) Ly5.2+ total BM
cells were mixed and transplanted into lethally irradiated (11 Gy) Ly5.1+ recip-
ient mice. After 3 months, one cohort of transplanted mice (n = 7) was irradi-
ated with 3 Gy. Ly5.2-chimerism in all hematopoietic compartments was
investigated after 3 months (PB, BM, BM-HSPCs, spleen, spleen-HSPCs,
and thymus) using flow cytometry. To investigate in vivo behavior of cells
transduced with the ZFNs, 1–4 3 105 sorted GFP+ Lin cells in 200 ml PBS/
mouse were transplanted into lethally irradiated (11 Gy) 3–6 months old
BoyJ (Ly5.1+) mice via retro-orbital injection. To determine effects of Chk2
overexpression and expression of Chk2 kinase-dead (KD), Ly 5.2+ BM cells
were transduced with the appropriate virus and equal numbers of cells were
mixed with (1–23 106) Ly5.1+ BM cells and transplanted into lethally irradiated
Ly5.1+ recipient mice. Peripheral blood (PB) chimerism was analyzed every
4 weeks by flow cytometry.
Flow Cytometry and Cell Sorting
For apoptosis and cell-cycle analyses, young (2–3 months) and aged
(18–24 month) C57BL/6 mice were irradiated with 3 or 7 Gy (n = 4). After
16 hr, 500 mgBrdU (Becton Dickinson [BD], Cell Cycle Kit) in 200 ml PBS/mouse
was injected intraperitoneally. After 45 min, the mice were sacrificed, BM
flushed, and mononuclear cells isolated by low-density centrifugation. 2 3
106 cells were stained with a cocktail of biotinylated lineage antibodies
after Fc block for 15 min: anti-Sca-1 (clone D7) (eBioscience), anti-c-Kit
(clone ACK2) (eBioscience), anti-CD34 (clone RAM34) (eBioscience), and
Streptavidin (eBioscience) for 1 hr on ice. Then cells were washed and incu-
bated in 13 Binding Buffer (BD, Cell Cycle Kit) with anti-Annexin V antibody
(BD, Apoptosis Detection Kit) for 20 min at RT. After washing cells were fixed
and permeabilized using BDCytofix/Cytoperm buffer (BD, Cell Cycle Kit). Cells
were kept overnight in 13 permeabilization/washing buffer (BD, Cell Cycle Kit)
and again permeabilized the next morning. Cells were then treated with 30 mg
DNase (BD, Cell Cycle Kit) in PBS with Ca2+/Mg2+ for 1.5 hr at 37C and after
washing incubated with anti-BrdU antibody (BD, Cell Cycle Kit) for 20 min
at room temperature (RT). Finally, after washing, 7AAD was added and cells
were immediately analyzed with a LSRII flow cytometer (BD Biosciences).
LT-HSCs were defined as Lin/c-Kit+/Sca-1+/CD34/low, LSK represents
Lin/c-Kit+/Sca-1+ cells, and hematopoietic progenitor cells were gated
Lin/c-Kit+. Apoptosis staining on Chk2 and Chk2 KD transduced c-Kit+ BM
cells was performed using the Annexin V antibody according to manufac-
turer’s instructions (BD, Apoptosis Detection Kit). LT-HSCs were isolated as
previously described (Florian et al., 2012).
8-oxo-dG Staining
Lineage-negative cells were harvested and incubated overnight at 37C (5%
CO2, 3% O2) in Hank’s balanced salt solution (HBSS) supplemented with
10% FBS. After 16 hr cells were irradiated with 2 Gy and incubated for
1 hr at 37C (5% CO2, 3% O2) in HBSS supplemented with 10% FBS.
Then surface marker staining and permeabilization was completed as
described in flow cytometry and cell sorting. Stained, fixed and permeabi-
lized cells were incubated with 30 mg DNase I (BD, Cell Cycle Kit) in PBS
with Ca2+/Mg2+ for 1 hr at 37C, washed, and stained overnight with the
anti-8-oxo-dG antibody (clone 2E2, Trevigen). After 16 hr, cells were washed
and stained with secondary antibody (Alexa 488 goat anti-mouse immuno-
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Immunofluorescence Staining
Immunofluorescence staining was performed exactly as described previously
(Florian et al., 2012).
Alkaline Comet Assay
LT-HSCs were incubated in IMDM medium (Lonza), 10% FBS, 1% penicillin/
streptomycin, and 2 mM L-glutamine at 37C (5% CO2, 3% O2) and irradi-
ated the next day with 2 Gy (2 min 20 s at RT), put on ice, and centrifuged
for 5 min at 1,500 rpm at RT. Cell were resuspended (zero time point) and
incubated at 37C (5% CO2, 3% O2) for 2 hr. Alkaline comet assay was per-
formed with CometSlides and Comet Assay Reagent Kit (Trevigen). 1,000–
1,500 LT-HSCs were encapsulated in 49 ml low-melting-point agarose on a
pre-warmed CometSlide and incubated at 4C in the dark for 30 min. Slides
were immersed in 44 ml pre-chilled lysis solution (4 ml DMSO [Sigma] in
40 ml lysis solution) on ice for 40 min, drained of excess lysis solution,
immersed into the alkaline solution for 30 min, and then placed into the elec-
trophoresis chamber with alkaline buffer (pH = 13) at 4C (30 V and 300 mA
for 30 min). Excess buffer was drained, slides immersed twice in cold ddH2O
for 10 min, fixed by immersing in cold 70% ethanol for 5 min, and dried
at 37C for 30 min. For DNA staining, 100 ml diluted SYBR green 1 (1 ml
10,0003 concentrated SYBR green 1 in 10 ml Tris-EDTA (TE) buffer
(10 mM Tris-HCL [pH 7.5] and 1 mM EDTA) were added onto each sample.
Cells were stained 5 min at 4C before excess SYBR solution was removed.
Dried slides were analyzed by fluorescence microscopy (Axio Observer Z1
microscope, Zeiss). Images of 50 cells of randomly chosen fields with equal
exposure time were captured. Comet tail length and tail moment (%DNA in
tail multiplied by tail length) were analyzed with the image analysis software
CometScore (TriTek Corporation).
Statistical Analysis
Normal distribution of data was implied, and the variance between the groups
was similar. Data are displayed as mean +1 SEM. All statistical analyses were
performed using Student’s t test with GraphPad Prism 6 software. In trans-
plantation experiments, only healthy engrafted mice were included in analysis.
For in vitro experiments, samples were excluded due to technical problems
(procedure or reagents). The number of biological repeats (n) is indicated in
figure legends.
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